Hospitals have an enormous financial incentive to use this toxic treatment, which frequently kills the patient, as the U.S. government pays a 20% upcharge on the entire hospital bill when remdesivir is used. Hospitals are also paid for the use of ventilation and for COVID deaths.
ORIGINAL LINK